Target intelligence / Profile preview

Sympathetic nervous system activity (central control) (SNS activity (CNS))

Target
SNS activity (CNS)
Molecular classification
Other (physiological network activity); not classified as receptor, enzyme, transporter, transcription factor, etc.
01

Overview

Central nervous system sympathetic activity refers to the regulation and generation of sympathetic nerve signals originating from central neural circuits (hypothalamus, medulla, spinal cord) that control the "fight or flight" response and ongoing homeostatic functions. Through descending projections and autonomic ganglia, these signals regulate vital processes including heart rate, vascular tone, and metabolism. Dysregulation of central sympathetic tone is implicated in hypertension, heart failure, stress disorders, and several other diseases. It is not a molecular target but a network activity subject to pharmacological modulation by agents acting at specific receptors (primarily alpha-2 adrenergic and imidazoline receptors) within CNS regions controlling autonomic function[8][6][1][9].

Other names
Central sympathetic outflowCentral SNS activationSympathetic tone (central)CNS sympathetic drive
02

Mechanism of action

Central alpha-2 adrenergic receptor activation (reduces sympathetic outflow)[8][6]; Imidazoline receptor activation (reduces sympathetic tone from CNS)[8]; Peripheral beta-adrenergic blockade (blocks effects of SNS, does not directly reduce central activity)[6]

03

Biological functions

Regulation of cardiovascular function (heart rate, blood pressure)[1][7][5]Modulation of metabolism[1][7]Control of stress responses ("fight or flight")[1][7][5]Regulation of digestive processes (inhibition during stress)[1][7][5]Influence on immune system and repair processes[7]
04

Disease associations

Cardiovascular disease (e.g., hypertension, heart failure, arrhythmia)[6][8]Metabolic syndrome/diabetes (through metabolic effects)[1]Neuropsychiatric disorders (stress, anxiety)[1]Other conditions linked to autonomic dysfunction
05

Safety considerations

Excessive inhibition: bradycardia, hypotension, sedation, depressionExcessive activation: hypertension, arrhythmia, cardiac events, anxiety, metabolic effects[6][8][1]
06

Interacting drugs

Indirect: Beta-blockers (reduce sympathetic effects peripherally)[6]

3 more in the full profile.

07

Biomarkers

Plasma norepinephrine/epinephrine (for general sympathetic activity)[6][7]Heart rate variability[6]Muscle sympathetic nerve activity (microneurography)[6][8]Blood pressure changes[6][8]

Beyond the preview

Go deeper on Sympathetic nervous system activity (central control) (SNS activity (CNS)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sympathetic nervous system activity (central control) (SNS activity (CNS)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call